Parkinson’s Disease: The long-awaited early detection technique is on the horizon
John Sacaria Thirusailam, once very active in life, was forced to leave his well-paid job at the age of 44 after being ...
AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease investigational gene therapy
Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...
GEN1d
Cholesterol Metabolite Implicated in Parkinson’s Disease Pathology
Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.
Too Old to Operate6d
In Parkinson’s Disease, Talk Therapy Addresses Unmet Psychological Needs
In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, problems/symptoms, and functioning.
Pharmabiz18h
AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation
AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation: Berlin, Germany Thursday, February 20, 2025, 10: ...
Cambridge Scientists Develop Brain Implants To Treat Parkinson’s Damage
Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...
CuraSen Therapeutics Announces First Subject Treated with CuraAX (CST-3056) in a Phase 1 Clinical Trial
CuraSen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral, rapid onset, small molecule drugs to ...
PMLiVE10h
FDA grants RMAT designation to AskBio’s Parkinson’s gene therapy candidate
The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to AskBio’s investigational Parkinson’s disease (PD) gene therapy. The FDA grants RMAT ...
pharmaphorum2d
Roche's Parkinson's hope fails second clinical trial
An experimental therapy for Parkinson's disease being developed by Roche ... system atrophy (MSA), another neurodegenerative disease with symptoms similar to Parkinson's. Roche has accentuated ...
Multiple System Atrophy Market Set to Experience Significant Growth with Breakthrough Therapies by 2034 | DelveInsight
Multiple system atrophy (MSA) is a rare neurological disorder that leads to the progressive deterioration of nerve cells in ...
Why your stool softener isn’t helping you poop — and the surprising way you can entertain kids with it
A pharmacist explained why your stool softener doesn’t seem to actually help when you’re constipated — and how to repurpose ...